Get Professional Valuation and Credit Risk Reports of Any Company in the World
New AI-Powered Free Company Valuation tool for any company in the world. Upload a PDF financial statement to receive an instant report with customizable forecasts, credit score, default probability and key financial metrics. Try Now for Free →
Get Professional Valuation and Credit Risk Reports of Any Company in the World
- Get an AI-powered company valuation or credit risk report in just 2 minutes
- Get reports of any company in the world with a financial statement in any language
- Upload a PDF financial statement to receive an instant report with customizable forecasts, credit score, default probability and key financial metrics
Ascendis Pharma Oncology Division A/S — Credit Rating and Financial Key Figures
CVR number: 41034076
Tuborg Boulevard 12, 2900 Hellerup
Income statement (kEUR)
2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|
| Fiscal period length | 12 | 12 | 12 | 12 | 12 |
| Net sales | |||||
| Gross profit | -46 676.71 | -62 367.39 | - 140 146.00 | -92 475.00 | -85 226.00 |
| Costs of management | -86.49 | -91.12 | -47.00 | -77.00 | -48.00 |
| EBIT | -46 763.20 | -62 458.51 | - 140 193.00 | -92 552.00 | -85 274.00 |
| Other financial income | 34.74 | 36.33 | 696.00 | 713.00 | 142.00 |
| Other financial expenses | -1 355.79 | -2 570.16 | -4 842.00 | -14 926.00 | -35 882.00 |
| Pre-tax profit | -48 084.25 | -64 992.34 | - 144 339.00 | - 106 765.00 | - 121 014.00 |
| Income taxes | 104.02 | 80.09 | 229.00 | 390.00 | 10 883.00 |
| Net earnings | -47 980.23 | -64 912.25 | - 144 110.00 | - 106 375.00 | - 110 131.00 |
Assets (kEUR)
2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|
| Intangible rights | 2 632.61 | |||
| Intangible assets total | 2 632.61 | |||
| Tangible assets total | ||||
| Investments total | ||||
| Long term receivables total | ||||
| Inventories total | ||||
| Prepayments and accrued income | 41.42 | 15.00 | ||
| Current other receivables | 2 484.45 | 5 125.56 | ||
| Short term receivables total | 2 525.87 | 5 125.56 | 15.00 | |
| Cash and bank deposits | 449.65 | 478.52 | 442.00 | 99.00 |
| Cash and cash equivalents | 449.65 | 478.52 | 442.00 | 99.00 |
| Balance sheet total (assets) | 5 608.14 | 5 604.08 | 457.00 | 99.00 |
Equity and liabilities (kEUR)
2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|
| Share capital | 120.46 | 120.46 | 120.00 | 120.00 | 120.00 |
| Shares repurchased | -64 912.25 | ||||
| Other reserves | 64 912.25 | ||||
| Retained earnings | -28 248.88 | -76 229.11 | - 141 141.00 | - 285 251.00 | - 391 626.00 |
| Profit of the financial year | -47 980.23 | -64 912.25 | - 144 110.00 | - 106 375.00 | - 110 131.00 |
| Shareholders equity total | -76 108.65 | - 141 020.90 | - 285 131.00 | - 391 506.00 | - 501 637.00 |
| Non-current owed to group member | 81 709.43 | 146 609.07 | 285 576.00 | 391 591.00 | 487 416.00 |
| Non-current liabilities total | 81 709.43 | 146 609.07 | 285 576.00 | 391 591.00 | 487 416.00 |
| Current trade creditors | 12.00 | 14.00 | 8.00 | ||
| Current owed to group member | 14 213.00 | ||||
| Short-term deferred tax liabilities | 15.90 | ||||
| Other non-interest bearing current liabilities | 7.36 | ||||
| Current liabilities total | 7.36 | 15.90 | 12.00 | 14.00 | 14 221.00 |
| Balance sheet total (liabilities) | 5 608.14 | 5 604.08 | 457.00 | 99.00 |
CreditReports API
- Company information
- Financial data
- Credit risk data
- All 400,000+ Danish companies
Try the full version of our system for free
- Professional credit risk reports
- Create your own estimates for any company
- Valuation analysis
- All 400,000+ Danish companies
- See instructions
... and more!
No registration needed.